Nanocapsules have become a promising drug delivery approach for fighting bacterial infections. Extract from Aloysia citriodora (Lemon verbena), known for its biological activities and culinary applications, was investigated as a potential source for topical antibacterial treatment. The aim was to prepare and optimize lipid nanocapsules loaded with Aloysia citriodora extract, using both water and ethanol as solvents. The production, optimization, and characterization of these nanocapsules were conducted employing a Box-Behnken design to examine the impact of various factors on the polydispersity index, particle size, and entrapment efficiency. Assessments were made on solubility, stability, pH, and homogeneity, along with evaluations of in-vitro drug release, dermatokinetic properties, antioxidant activity, and antibacterial effects. The physical stability and quality of the nanocapsules were demonstrated with an average size of 104.6 nm and a polydispersity index (PDI) of 0.246. The encapsulation effectiveness was determined to be 87.08 %. In-vitro drug release studies revealed sustained release characteristics by the Korsmeyer Peppas model. Additionally, the formulation displayed significant antioxidant activity and promising antibacterial effects against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Stability tests over ninety days showed that the formulation maintained structural integrity, consistent pH values and drug content, and good spreadability. The nanoformulation combined the benefits of Aloysia citriodora extract with the advantages of nanocapsule technology, offering a novel approach to addressing various pharmaceutical and antimicrobial challenges.
Read full abstract